HK1133260A1 - Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes - Google Patents

Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes

Info

Publication number
HK1133260A1
HK1133260A1 HK10100570.6A HK10100570A HK1133260A1 HK 1133260 A1 HK1133260 A1 HK 1133260A1 HK 10100570 A HK10100570 A HK 10100570A HK 1133260 A1 HK1133260 A1 HK 1133260A1
Authority
HK
Hong Kong
Prior art keywords
receptorsub
diazabicycloalkanes
nicotinic acetylcholine
type selective
amides
Prior art date
Application number
HK10100570.6A
Other languages
English (en)
Inventor
Anatoly Mazurov
Lan Miao
Yun-De Xiao
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targacept Inc filed Critical Targacept Inc
Priority to HK11103927.9A priority Critical patent/HK1149751A1/xx
Publication of HK1133260A1 publication Critical patent/HK1133260A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK10100570.6A 2006-11-02 2010-01-20 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes HK1133260A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HK11103927.9A HK1149751A1 (en) 2006-11-02 2010-01-20 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85607906P 2006-11-02 2006-11-02
PCT/US2007/083330 WO2008057938A1 (en) 2006-11-02 2007-11-01 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes

Publications (1)

Publication Number Publication Date
HK1133260A1 true HK1133260A1 (en) 2010-03-19

Family

ID=39233054

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11103927.9A HK1149751A1 (en) 2006-11-02 2010-01-20 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types
HK10100570.6A HK1133260A1 (en) 2006-11-02 2010-01-20 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK11103927.9A HK1149751A1 (en) 2006-11-02 2010-01-20 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types

Country Status (33)

Country Link
US (6) US8114889B2 (ar)
EP (2) EP2284171B1 (ar)
JP (2) JP5539723B2 (ar)
KR (2) KR101415705B1 (ar)
CN (4) CN102838605B (ar)
AR (2) AR063451A1 (ar)
AT (2) ATE509022T1 (ar)
AU (2) AU2007317433B2 (ar)
BR (2) BRPI0722387A2 (ar)
CA (1) CA2663925C (ar)
CL (1) CL2007003155A1 (ar)
CO (1) CO6180435A2 (ar)
CY (1) CY1112374T1 (ar)
DK (1) DK2094703T3 (ar)
ES (2) ES2395157T3 (ar)
HK (2) HK1149751A1 (ar)
HR (1) HRP20110570T1 (ar)
IL (2) IL197618A (ar)
MX (1) MX2009004801A (ar)
MY (2) MY156730A (ar)
NO (1) NO20091251L (ar)
NZ (2) NZ575557A (ar)
PE (2) PE20110671A1 (ar)
PL (1) PL2094703T3 (ar)
PT (1) PT2094703E (ar)
RS (1) RS51834B (ar)
RU (2) RU2517693C2 (ar)
SA (1) SA07280584B1 (ar)
SI (1) SI2094703T1 (ar)
TW (3) TWI405763B (ar)
UA (2) UA106718C2 (ar)
UY (1) UY30686A1 (ar)
WO (1) WO2008057938A1 (ar)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI405763B (zh) * 2006-11-02 2013-08-21 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
KR20100122508A (ko) * 2008-03-05 2010-11-22 타가셉트 인코포레이티드 디아자비시클로알칸의 니코틴 아세틸콜린 수용체 서브-타입 선택성 아미드
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
ATE552255T1 (de) 2008-06-05 2012-04-15 Glaxo Group Ltd 4-aminoindazole
JP5508400B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド Ｐｉ３キナーゼの阻害剤としてのベンズピラゾール誘導体
JP5502076B2 (ja) 2008-06-05 2014-05-28 グラクソ グループ リミテッド 新規化合物
WO2010028011A1 (en) * 2008-09-05 2010-03-11 Targacept, Inc. Amides of diazabicyclononanes and uses thereof
JP2012502039A (ja) * 2008-09-05 2012-01-26 ターガセプト，インコーポレイテッド ジアザビシクロオクタンのアミド及びその用途
WO2010080757A2 (en) 2009-01-07 2010-07-15 Astrazeneca Ab Combinations with an alpha-4beta-2 nicotinic agonist
WO2010102958A1 (en) 2009-03-09 2010-09-16 Glaxo Group Limited 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
PL2424864T3 (pl) 2009-04-30 2015-05-29 Glaxo Group Ltd Podstawione oksazolami indazole jako inhibitory kinazy pi3
RU2417082C2 (ru) * 2009-07-14 2011-04-27 Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
EP2513085B1 (en) 2009-11-18 2016-09-28 Suven Life Sciences Limited Bicyclic compounds as alpha4beta2 nicotinic acetylcholine receptor ligands
SG181502A1 (en) 2009-12-29 2012-07-30 Suven Life Sciences Ltd Alpha4beta2 neuronal nicotinic acetylcholine receptor ligands
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
KR20160087900A (ko) 2013-11-26 2016-07-22 에프. 호프만-라 로슈 아게 신규한 옥타하이드로-사이클로부타[1,2-c；3,4-c'']다이피롤-2-일
CN106103446B (zh) 2014-03-26 2019-07-30 豪夫迈·罗氏有限公司 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的二环化合物
ES2848977T5 (es) 2014-10-20 2024-06-06 Oyster Point Pharma Inc Métodos de tratamiento de afecciones oculares
AU2016316717B2 (en) 2015-09-04 2021-02-18 F. Hoffmann-La Roche Ag Phenoxymethyl derivatives
MX2018001430A (es) 2015-09-24 2018-04-20 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
KR20180053408A (ko) 2015-09-24 2018-05-21 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서의 신규한 이환형 화합물
WO2017050792A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag Bicyclic compounds as atx inhibitors
EP3353180B1 (en) 2015-09-24 2022-03-16 F. Hoffmann-La Roche AG Bicyclic compounds as atx inhibitors
KR102485299B1 (ko) 2016-04-07 2023-01-06 오이스터 포인트 파마 인코포레이티드 안구 장애의 치료 방법
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
RU2019132254A (ru) 2017-03-16 2021-04-16 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
NZ763766A (en) 2017-03-20 2023-07-28 Novo Nordisk Healthcare Ag Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
EP3852791B1 (en) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Activating pyruvate kinase r
BR112021005188A2 (pt) 2018-09-19 2021-06-08 Forma Therapeutics, Inc. tratamento de anemia falciforme com um composto de ativação de piruvato cinase r

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU482990A1 (ru) * 1973-09-03 1978-04-15 Предприятие П/Я Г-4059 Способ получени 1,4-диазабицикло(2,2,2)-октана
US4922901A (en) * 1988-09-08 1990-05-08 R. J. Reynolds Tobacco Company Drug delivery articles utilizing electrical energy
IL107184A (en) 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5852041A (en) * 1993-04-07 1998-12-22 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acethylcholine receptors
US5493026A (en) * 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
RU2124014C1 (ru) * 1993-12-29 1998-12-27 Пфайзер Инк. Диазабициклические соединения и содержащая их фармацевтическая композиция
US5457121A (en) 1994-09-02 1995-10-10 Eli Lilly And Company Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5585388A (en) 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
IL118279A (en) 1995-06-07 2006-10-05 Abbott Lab Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
US5616716A (en) 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
US5663356A (en) 1996-04-23 1997-09-02 Ruecroft; Graham Method for preparation of aryl substituted alefinic secondary amino compounds
US5726189A (en) 1996-05-03 1998-03-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
AU1996301A (en) * 1999-12-14 2001-06-25 Neurosearch A/S Novel heteroaryl-diazabicycloalkanes
US6809105B2 (en) * 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
EP1368354A1 (en) 2001-03-07 2003-12-10 Pfizer Products Inc. Modulators of chemokine receptor activity
CN1229375C (zh) * 2001-07-06 2005-11-30 神经研究公司 烟碱型乙酰胆碱受体抑制剂化合物、其制备和应用
SE0202430D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202465D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
WO2004076453A1 (en) * 2003-02-27 2004-09-10 Neurosearch A/S Novel diazabicyclic aryl derivatives
CN1317280C (zh) * 2003-02-27 2007-05-23 神经研究公司 新的二氮杂双环芳基衍生物
US7399765B2 (en) 2003-09-19 2008-07-15 Abbott Laboratories Substituted diazabicycloalkane derivatives
US7365193B2 (en) * 2004-02-04 2008-04-29 Abbott Laboratories Amino-substituted tricyclic derivatives and methods of use
EP1761542B1 (en) * 2004-06-09 2008-01-02 F.Hoffmann-La Roche Ag Octahydropyrrolo[3,4-c]pyrrole derivatives an their use as antiviral agents
CN101031572B (zh) 2004-07-22 2010-12-08 坎布里Ip风险投资有限合伙公司 (r/s)利福霉素衍生物，它们的制备和药物组合物
WO2006124748A2 (en) * 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Multicyclic compounds and methods of their use
TWI405763B (zh) * 2006-11-02 2013-08-21 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺

Also Published As

Publication number Publication date
TW201114424A (en) 2011-05-01
CO6180435A2 (es) 2010-07-19
RU2009138600A (ru) 2011-04-27
IL209026A0 (en) 2011-01-31
MY156730A (en) 2016-03-15
HK1149751A1 (en) 2011-10-14
AU2010219323B2 (en) 2012-05-03
CN101528745A (zh) 2009-09-09
TWI454262B (zh) 2014-10-01
US20130005789A1 (en) 2013-01-03
ES2395157T3 (es) 2013-02-08
JP5539723B2 (ja) 2014-07-02
TW201305176A (zh) 2013-02-01
US20150080576A1 (en) 2015-03-19
RU2009120674A (ru) 2010-12-10
PT2094703E (pt) 2011-07-22
RS51834B (en) 2012-02-29
RU2517693C2 (ru) 2014-05-27
CN101528745B (zh) 2011-09-14
MY145602A (en) 2012-03-15
US8268860B2 (en) 2012-09-18
KR101415705B1 (ko) 2014-07-04
EP2094703B1 (en) 2011-05-11
EP2094703A1 (en) 2009-09-02
SI2094703T1 (sl) 2011-07-29
CA2663925A1 (en) 2008-05-15
UA98944C2 (ru) 2012-07-10
JP2013056919A (ja) 2013-03-28
NZ575557A (en) 2011-01-28
CN102942569A (zh) 2013-02-27
TWI404532B (zh) 2013-08-11
IL209026A (en) 2014-03-31
BRPI0717930A2 (pt) 2011-05-10
BRPI0722387A2 (pt) 2023-02-23
CY1112374T1 (el) 2015-12-09
US20100081683A1 (en) 2010-04-01
EP2284171A1 (en) 2011-02-16
CN102942569B (zh) 2015-10-28
PE20110671A1 (es) 2011-10-20
ATE509022T1 (de) 2011-05-15
AU2007317433A1 (en) 2008-05-15
TW200826935A (en) 2008-07-01
US8921410B2 (en) 2014-12-30
DK2094703T3 (da) 2011-08-29
US8859609B2 (en) 2014-10-14
IL197618A0 (en) 2009-12-24
MX2009004801A (es) 2009-07-31
US8114889B2 (en) 2012-02-14
ES2395212T3 (es) 2013-02-11
CN102020646B (zh) 2013-11-13
IL197618A (en) 2013-09-30
ATE545646T1 (de) 2012-03-15
CN102020646A (zh) 2011-04-20
SA07280584B1 (ar) 2010-11-02
WO2008057938A1 (en) 2008-05-15
CA2663925C (en) 2015-04-21
JP2010509230A (ja) 2010-03-25
CN102838605B (zh) 2017-04-26
CL2007003155A1 (es) 2008-05-16
PL2094703T3 (pl) 2011-10-31
KR20090074051A (ko) 2009-07-03
TWI405763B (zh) 2013-08-21
US9580434B2 (en) 2017-02-28
JP5739398B2 (ja) 2015-06-24
AR063451A1 (es) 2009-01-28
PE20081441A1 (es) 2008-10-30
RU2448969C2 (ru) 2012-04-27
UY30686A1 (es) 2009-08-03
AU2010219323A1 (en) 2010-09-30
CN102838605A (zh) 2012-12-26
HRP20110570T1 (hr) 2011-09-30
US20160039833A1 (en) 2016-02-11
US20100173932A1 (en) 2010-07-08
EP2284171B1 (en) 2012-02-15
AR079840A2 (es) 2012-02-22
UA106718C2 (uk) 2014-10-10
US20120289572A1 (en) 2012-11-15
NZ587847A (en) 2011-09-30
AU2007317433B2 (en) 2012-05-10
NO20091251L (no) 2009-05-28
KR20100124356A (ko) 2010-11-26

Similar Documents

Publication Publication Date Title
HK1133260A1 (en) Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
HUS000510I2 (hu) Oxatiapiprolin vagy N-oxidja vagy sója
HRP20130626T1 (en) Pyridinone compounds
IL227668A0 (en) Azadmantane derivatives and their uses as ligands for nicotinic acylcholine receptors
EP2000245A4 (en) WELDING PROCESS
DK2035004T3 (en) Phenylsubstituerede pyrazinoylguanidin-natriumkanalblokkere med beta-agonistaktivitet
HK1135090A1 (en) Pyridine carboxamides as 11-beta-hsd1 inhibitors
EP2082818A4 (en) RACK AND MANUFACTURING METHOD THEREFOR
ZA200901974B (en) Thiophene-sulfonic acid picolyl amides
EP2013903A4 (en) STRESSOR INTEGRATION AND METHOD THEREFOR
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
GB0705854D0 (en) Methods of construction
GB0608966D0 (en) Method and product
ZA200809112B (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
HK1128661A1 (en) Time recorder
GB0607488D0 (en) Composition and process
GB0605004D0 (en) Composition and process
GB0610059D0 (en) Uses and methods
GB0607493D0 (en) Composition and process
TWM298391U (en) Improved structure of bar
AU2012205208B2 (en) Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
IL194758A0 (en) N-oxides of pyridylmethylpipertazine and-piperidine derivatives
GB0622809D0 (en) Teaching aid
GB0624071D0 (en) Purification methods and materials
IL187936A0 (en) Joining device of passage block

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: DELETION OF INVENTOR: WHITAKER, REGINA C. AKIREDDY, SRINIVISA RAO HAMMOND, PHILIP S. MILLER, CRAIG H. BREINING, SCOTT R. MELVIN, MATT S. MURTHY, V. SRINIVASA - THE FOLLOWING ITEMS IN BOLD SHOW THE CORRECTED DATA OF THE NOTICE OF REQUESTS TO - DATED 1.6.2007

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151101